KR101608882B1 - Cosmetic Composition Comprising Golden Peanut Extracts - Google Patents
Cosmetic Composition Comprising Golden Peanut Extracts Download PDFInfo
- Publication number
- KR101608882B1 KR101608882B1 KR1020140044128A KR20140044128A KR101608882B1 KR 101608882 B1 KR101608882 B1 KR 101608882B1 KR 1020140044128 A KR1020140044128 A KR 1020140044128A KR 20140044128 A KR20140044128 A KR 20140044128A KR 101608882 B1 KR101608882 B1 KR 101608882B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- peanut
- golden
- cosmetic composition
- peanut extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 83
- 235000020232 peanut Nutrition 0.000 title claims abstract description 83
- 235000010777 Arachis hypogaea Nutrition 0.000 title claims abstract description 75
- 235000017060 Arachis glabrata Nutrition 0.000 title claims abstract description 74
- 235000018262 Arachis monticola Nutrition 0.000 title claims abstract description 74
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 241001553178 Arachis glabrata Species 0.000 title claims abstract 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 6
- 230000004151 fermentation Effects 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 15
- 230000037394 skin elasticity Effects 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 6
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 238000005187 foaming Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 230000009759 skin aging Effects 0.000 abstract description 9
- 230000004663 cell proliferation Effects 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract 1
- 244000105624 Arachis hypogaea Species 0.000 description 73
- 230000000052 comparative effect Effects 0.000 description 27
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 22
- 238000009472 formulation Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000001569 carbon dioxide Substances 0.000 description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 230000012292 cell migration Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 240000004922 Vigna radiata Species 0.000 description 8
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 8
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- -1 super oxide radicals Chemical class 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 229940069765 bean extract Drugs 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000006184 cosolvent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 235000021283 resveratrol Nutrition 0.000 description 3
- 229940016667 resveratrol Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000280 phytoalexin Substances 0.000 description 2
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 금이온수를 이용하여 재배한 황금땅콩을 물, 유기용매 또는 초음파, 초임계, 발효법, 포제법등의 추출방법을 이용하여 얻은 황금땅콩 추출물을 포함하는 피부 화장료 조성물에 관한 것이다. 본 발명에 따른 황금땅콩 추출물은 피부 항산화 효과 및 세포 증식 효과가 뛰어나서 피부 노화 예방 효과가 뛰어나며 본 발명은 이러한 황금땅콩 추출물을 함유하는 화장료 조성물에 관한 것이다.The present invention relates to a skin cosmetic composition comprising a golden peanut extract obtained by using water, an organic solvent, or an extraction method such as supersonic, supercritical, fermentation, or spraying methods. The golden peanut extract according to the present invention is excellent in skin antioxidative effect and cell proliferation effect and thus has excellent skin aging prevention effect. The present invention relates to a cosmetic composition containing such a golden peanut extract.
Description
본 발명은 땅콩 추출물을 포함하는 화장료 조성물에 관한 것으로서, 상세하게는 금 이온수를 사용하여 재배한 땅콩을 물, 유기용매 또는 초음파, 초임계, 발효법, 포제법 등의 추출방법을 이용하여 얻은 황금땅콩 추출물을 포함하는 피부 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition comprising a peanut extract. More particularly, the present invention relates to a cosmetic composition comprising peanut extract, and more particularly to a cosmetic composition containing peanut extract obtained by using water, organic solvent, And an extract thereof.
일반적으로 피부 노화를 설명하는 여러 가지 이론 중에서 체내외의 여러 가지 원인에 의해서 발생되는 자유라디칼에 의해서 피부가 노화된다는 자유라디칼 이론이 가장 타당성이 있는 이론으로 간주되고 있다. 자유라디칼은 화학적으로 반응성이 매우 큰 화학물질로서, 인체 내에서는 여러 가지 원인, 즉 자외선, 방사선, 매연, 담배연기, 스트레스 등의 외부적 요인과 체내의 미토콘드리아 및 백혈구의 대사과정에 의해서 생성되어 다단계의 연쇄반응을 통하여 세포막의 구성성분인 지질의 과산화를 일으키게 된다.In general, the free radical theory that skin is aged by free radicals caused by various causes outside the body among various theories that explain skin aging is regarded as the most valid theory. Free radicals are very chemically reactive chemicals that are generated by the external factors such as ultraviolet rays, radiation, smoke, smoke, tobacco smoke, and stress in the human body and metabolic processes of mitochondria and leukocytes in the body, The peroxidation of the lipid component of the cell membrane.
피부 노화와 관련 있는 자유라디칼의 대부분은 활성 산소종(Reactive Oxygen Species, ROS)이다. 그 종류로는 수퍼옥사이드 라디칼(Super oxide radical), 과산화수소(H2O2), 하이드록시 라디칼(Hydroxy radical), 단일상태의 산소(Singlet oxygen) 등이 있다. 이들에 의해 일어나는 지질의 과산화는 라디칼, 과산화물, 알데하이드(aldehyde) 및 에폭사이드(epoxide)의 다양한 활성 산소종을 발생시키고, DNA, RNA, 단백질, 세포막 및 세포 구조에 치명적인 손상을 입힌다.Most of the free radicals associated with skin aging are Reactive Oxygen Species (ROS). They include super oxide radicals, hydrogen peroxide (H 2 O 2 ), hydroxy radicals, and singlet oxygen. The lipid peroxidation caused by these causes various active oxygen species of radicals, peroxides, aldehydes and epoxides and damages DNA, RNA, protein, cell membrane and cell structure.
따라서 지금까지 피부노화 억제를 위해 가장 많이 연구되고 있는 분야 중 하나가 항산화제에 관한 연구이다. 수퍼옥사이드 라디칼(O2 -)과 하이드록시라디칼(OH)과 같은 라디칼과 과산화수소(H2O2)와 같은 비라디칼에 의해 피부가 산화적 스트레스를 받음으로써 세포가 손상되고 피부노화 현상이 촉진되는 것으로 알려졌다. 따라서 각종 산화물질에 대한 직접적인 항산화 효과뿐만 아니라 피부 각질세포로부터 TNF-a 및 IL-8의 분비 억제효과는 세포의 산화적 스트레스를 억제하고, 이후 각질세포로부터 분비되는 TNF-a 및 IL-8에 의한 랑게르한스세포, 섬유아세포(fibroblast), 및 멜라노사이트(melanocyte) 등의 주위 피부세포에 2차 반응을 억제하여 피부노화를 근본적으로 예방하는 항산화제에 관한 연구가 지속적으로 이루어지고 있다.So far, research on antioxidants has been one of the most studied areas for inhibiting skin aging. Radicals such as superoxide radicals (O 2 - ) and hydroxyl radicals (OH) and non-radicals such as hydrogen peroxide (H 2 O 2 ) cause oxidative stress on the skin, thereby damaging cells and promoting skin aging . Therefore, not only the direct antioxidant effect on various oxidizing substances but also the suppressive effect of TNF-a and IL-8 secretion from keratinocytes suppresses oxidative stress of cells, and after that, TNF-a and IL-8 secreted from keratinocytes There have been ongoing studies on antioxidants that inhibit secondary reactions to peripheral skin cells such as Langerhans cells, fibroblasts, and melanocytes to fundamentally prevent skin aging.
이러한 활성산소에 의한 피부 손상을 막아주는 항산화제들은 수퍼옥사이드 디스뮤타아제(super oxide dismutase, SOD), 카탈라아제(catalase) 등의 효소와 토코페롤(tocopherol, vitamin E), beta-카로틴(carotene), 아스코르빈산(ascorbic acid, vitamin C) 및 글루타치온(glutathione)과 같은 지용성 및 수용성 항산화제 또는 라디칼 소거제들이 포함된다.These antioxidants that prevent skin damage by active oxygen include superoxide dismutase (SOD), enzymes such as catalase and tocopherol (vitamin E), beta- carotene, Lipid soluble and water soluble antioxidants or radical scavengers such as ascorbic acid (vitamin C) and glutathione.
위에서 기술한 바와 같이, 자유라디칼형 산소 또는 활성 산소종은 피부 노화와 관련성이 크기 때문에 종래에는 화장료에 수퍼옥사이드 디스뮤타아제, 비타민 E 유도체, 비타민 C 및 그 유도체, 플라보노이드(flavonoid) 등을 화장료에 배합함으로써 피부 노화 방지 효과를 달성하려는 노력이 많이 있었다. 하지만, 화장료에 상기 성분들을 배합하는 경우, 안전성(safety), 안정성(stability) 등이 좋지 못하여 실질적인 효과를 기대하기 어려웠다.As described above, since free radical oxygen or reactive oxygen species are highly related to skin aging, conventionally, superoxide dismutase, vitamin E derivatives, vitamin C and derivatives thereof, and flavonoids have been added to cosmetics There have been many efforts to achieve skin anti-aging effects by blending. However, when the above ingredients are blended in cosmetics, safety, stability, and the like are poor, and it is difficult to expect a substantial effect.
따라서, 위에서 기술한 종래 기술의 문제점을 해결하기 위해 항산화 효과가 우수하고 세포 증식 효과가 우수한 제품 및 원료 개발의 필요성이 계속하여 대두되고 있는 실정이다.Accordingly, in order to solve the problems of the prior art described above, there is a continuing need for the development of products and raw materials having excellent antioxidative effect and excellent cell proliferation effect.
본 발명은 항산화 효과가 우수하고 세포 증식 효과가 우수한 화장료 조성물을 제공하는 것을 목적으로 한다. 또한, 피부 내 활성 산소를 제거하고 세포 손상 물질로부터 피부를 보호하는 효과가 뛰어나며, 피부세포의 증식을 촉진시켜 콜라겐 생합성을 향상시키는 효과를 통해 항노화 효과를 가지는 화장료 조성물을 제공하는 데 그 목적이 있다. An object of the present invention is to provide a cosmetic composition excellent in antioxidative effect and excellent in cell proliferation effect. It is another object of the present invention to provide a cosmetic composition having an anti-aging effect through an effect of removing active oxygen in the skin and protecting the skin from cell damaging substances and enhancing collagen biosynthesis by promoting proliferation of skin cells have.
상기한 과제는, 금 이온수를 사용하여 재배한 땅콩(이하 ‘황금땅콩’이라 한다) 추출물을 함유하는 화장료 조성물에 의해 달성된다.The above-mentioned problem is achieved by a cosmetic composition containing peanut (hereinafter referred to as 'golden peanut') extract grown using gold ionized water.
바람직하게는, 상기 황금땅콩 추출물은 땅콩 열매의 추출물인 것을 특징으로 한다.Preferably, the golden peanut extract is an extract of peanut fruit.
또한 상기 황금땅콩 추출물은 피부 항산화 효과, 세포 이동 효과 및 피부 탄력 개선 효과를 갖는 것을 특징으로 한다.The peanut extract of the present invention is also characterized by its antioxidant effect on skin, cell migration effect and skin elasticity.
또한, 상기 황금땅콩 추출물은 화장료 총 중량에 대하여 0.001 내지 30.0%(w/w)를 함유할 수 있다. In addition, the golden peanut extract may contain 0.001 to 30.0% (w / w) based on the total weight of the cosmetic.
바람직하게는, 상기 황금땅콩 추출물은 땅콩을 물, 탄소수 1-4개의 무수 또는 함수 저급 알코올, 프로필렌글리콜, 부틸렌글리콜, 글리세린, 아세톤, 에틸 아세테이트, 부틸 아세테이트, 클로로포름, 디에틸에테르, 디클로로메탄, 헥산 및 이들의 혼합물로 구성된 군으로부터 선택되는 추출용매를 이용한 용매 추출법을 이용하여 추출하는 통상적인 추출 방법, 초음파 추출법, 초임계 추출법, 발효법 및 포제법으로 이루어진 군에서 선택된 방법으로 얻어질 수 있다.Preferably, the golden peanut extract is prepared by dissolving the peanut in water, anhydrous or lower alcohols having 1-4 carbons, propylene glycol, butylene glycol, glycerin, acetone, ethyl acetate, butyl acetate, chloroform, diethyl ether, dichloromethane, A supercritical extraction method, a fermentation method, and a pulverization method, which comprises extracting by using a solvent extraction method using an extraction solvent selected from the group consisting of hexane, hexane, and mixtures thereof.
또한, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 제형을 가질 수 있다.The cosmetic composition may also be selected from the group consisting of solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, It can have a formulation.
본 발명은 금이온수를 이용하여 재배한 땅콩 추출물을 포함하는 피부 노화 방지용 화장료 조성물에 관한 것이다. 본 발명의 화장료 조성물에 포함된 유효성분인 황금땅콩 추출물은 피부 항산화 작용 및 세포 이동 효과가 뛰어나고 피부 탄력 개선 효과가 뛰어나므로 피부 노화 방지용 화장료로서 우수한 효능을 가지고 있다.The present invention relates to a cosmetic composition for preventing skin aging comprising peanut extract grown using gold ionized water. The golden peanut extract, which is an active ingredient contained in the cosmetic composition of the present invention, has excellent antioxidative and cell migration effects on skin and excellent skin elasticity, and thus has excellent efficacy as a cosmetic for preventing skin aging.
도 1a 내지 도 1c는 본 발명의 황금땅콩 추출물의 항산화 효과 측정결과를 나타낸 것이다.
도 2는 본 발명의 황금땅콩 추출물(2a), 땅콩 추출물(2b), 녹두 추출물(2c), 대조군(3d)의 세포 이동 효과를 나타낸 것이다.FIGS. 1A to 1C show the results of measuring the antioxidative effect of the golden peanut extract of the present invention.
2 shows the cell migration effect of the peanut extract (2a), peanut extract (2b), mung bean extract (2c) and control group (3d) of the present invention.
본 발명은 땅콩 추출물을 포함하는 피부 화장료 조성물을 제공한다.The present invention provides a skin cosmetic composition comprising peanut extract.
본 발명의 화장료 조성물에서 유효성분으로 이용되는 땅콩(Arachis Hypogaea)은 고단백, 고지방과 비타민 B군이 풍부하게 들어있는 고칼로리 식품이다. 땅콩은 세포를 튼튼히 하고 적혈구를 증가시키며 철의 흡수를 돕는 작용을 하는 비타민 E도 많이 들어있으며, 땅콩의 지방질에 들어있는 불포화 지방산은 콜레스테롤 수치를 떨어뜨리는 작용을 하는 것으로 알려져 있다. 또한 땅콩은 혈관벽을 청소하여 피를 맑게 하고, 땅콩의 비타민 E 성분이 동맥경화증의 예방에 뛰어난 효과를 발휘해 노화방지에 좋은 것으로 알려져 있다.The peanut ( Arachis Hypogaea ) used as an active ingredient in the cosmetic composition of the present invention is a high-calorie food rich in high-protein, high-fat and vitamin B group. It is known that peanuts contain a lot of vitamin E, which strengthens cells, increases red blood cells, and helps iron absorption. Unsaturated fatty acids in peanut fats are known to lower cholesterol levels. Also, peanuts cleanse blood vessels to clear blood, and vitamin E ingredients in peanuts are known to be effective in preventing aging by exerting an excellent effect in the prevention of arteriosclerosis.
또한, 최근 들어 땅콩에서 항암물질인 레스베라트롤 (resveratrol)의 존재도 확인되었다. 레스베라트롤은 땅콩이 외부로부터의 물리적 자극이나 곰팡이의 침입에 대항해서 만들어내는 항독성물질인 피토알렉신(phytoalexin)의 일종으로서, 피토알렉신이란 식물들이 외부의 생물학적 또는 비생물학적 자극에 대해 자기 자신을 보호하려고 만들어내는 물질들을 총칭한다. 레스베라트롤은 항암작용, 항혈전작용, 항산화작용, 심혈관계질환의 발병을 낮추는 등의 효과를 나타낸다고 보고 되어 있다(YJ Surh et al. Cancer Letters, 140:1-10, 1999; L Front. Life Sciences, 66:663-673, 2000). 또한 본 발명의 조성물에서 유효성분으로 이용되는 땅콩은 금이온수가 함유된 제주도 우도산 황금땅콩을 구입하여 추출한 추출물을 이용하였다.In addition, the presence of resveratrol, an anticancer substance, in peanuts has recently been confirmed. Resveratrol is a type of phytoalexin, an anti-toxic substance that peanuts produce against external physical stimuli or fungal infestations. Phytoalexin protects itself against external biological or non-biological stimuli. It is a collective term for the substances that it produces. Resveratrol has been reported to exhibit anticancer, antithrombotic, antioxidant, and lowering the incidence of cardiovascular disease (YJ Surh et al. Cancer Letters, 140: 1-10, 1999. L Front. Life Sciences, 66: 663-673,2000). Also, the peanut used as an active ingredient in the composition of the present invention was obtained by purchasing and extracting golden peanut from Udo Mountain, Jeju Island containing gold ionized water.
본 발명에서는 대한민국 특허등록 제10-0555584호의 ‘전기분해법을 이용한 금속나노입자 제조방법’에 기재된 기술인 금 나노 이온수를 땅콩에 시비한 후 수확한 땅콩(황금땅콩)을 구매하여 사용하였다. 본 발명에서 사용된 황금땅콩은 "농업회사법인 주식회사 황금우도땅콩"에서 구입하였다. 황금땅콩은 2nm 이하의 금나노입자 99.9%를 증류수에 녹인 후, 3차례에 걸쳐 시비하여 재배한 것이다.In the present invention, harvested peanut (golden peanut) after the application of the gold nano-ionized water to the peanut, which is the technology described in Korean Patent Registration No. 10-0555584, 'Method for manufacturing metal nanoparticles using electrolysis method' was purchased and used. The golden peanut used in the present invention was purchased from " Golden Udo Peanut Co., Ltd. " Golden peanuts were prepared by dissolving 99.9% of gold nanoparticles of 2 nm or less in distilled water and then fertilizing them three times.
본 발명의 황금땅콩 추출물은 당업계에 공지된 통상의 방법에 따라, 즉, 통상적인 온도와 압력의 조건하에서, 통상적인 용매를 사용하여(예컨대, 물, 탄소수 1-4개의 무수 또는 함수 저급 알코올, 아세톤, 에틸아세테이트, 부틸아세테이트 또는 1,3 부틸렌 글리콜을 가하여) 제조될 수 있다.The golden peanut extract of the present invention can be prepared by conventional methods known in the art, that is, under the conditions of ordinary temperature and pressure, using a conventional solvent (e.g., water, anhydrous or hydrous lower alcohol , Acetone, ethyl acetate, butyl acetate or 1,3-butylene glycol).
바람직한 실시예에 의하면, 본 발명의 황금땅콩 추출물의 제조 방법은 다음과 같다. 먼저 황금땅콩을 껍질을 제거한 후 정제수로 세척한 후 건조하고 작은 조각으로 파쇄 한 뒤, 여기에 건조 중량의 1∼10배의 물, 탄소수 1∼4개의 무수 또는 함수 저급 알코올, 아세톤, 에틸아세테이트, 부틸아세테이트 또는 1,3-부틸렌 글리콜 등을 가한다. 그 후 냉각 콘덴서가 장치되어 유효성분이 증발되는 것을 방지한 상태에서 40∼100℃에서 3∼20시간 가열하여 추출하거나, 4∼40℃에서 1∼15일간 추출하고 회전 감압 증발기로 완전히 건조시켜 제조한다. 이때 1,3-부틸렌 글리콜의 경우에는 회전 감압 증발기를 이용하여 건조시키기 어려우므로 직접 위의 조건에서 추출한 후 건조 감량이 1%(w/v)되게 조정하여 본 발명의 화장료에 이용한다.According to a preferred embodiment, the method for preparing the golden peanut extract of the present invention is as follows. First, the peanut was peeled off, washed with purified water, dried and crushed into small pieces, and then water, 1 to 10 times the weight of dry weight, anhydrous or lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, Butyl acetate or 1,3-butylene glycol. Then, it is extracted by heating at 40 to 100 ° C for 3 to 20 hours or at 4 to 40 ° C for 1 to 15 days in a state where a cooling condenser is installed to prevent evaporation of the active ingredient, and is completely dried by a rotary evaporator . In this case, in the case of 1,3-butylene glycol, it is difficult to dry using a rotary evaporator, so it is extracted directly under the above conditions and adjusted to a 1% (w / v) loss on drying.
한편, 본 발명의 황금땅콩 추출물은 상술한 추출법에 의한 추출물뿐만 아니라, 이산화탄소에 의한 감압 및 고온에 의한 초임계 추출법 또는 초음파 추출법에 의한 추출물도 포함한다. Meanwhile, the golden peanut extract of the present invention includes extracts by supercritical extraction or ultrasonic extraction by decompression by carbon dioxide and high temperature as well as extracts by the above extraction method.
이산화탄소에 의한 감압 및 고온에 의한 초임계추출법에 의한 추출법은 초임계 유체 추출법(supercritical fluid extraction)을 의미하는 것이다. 일반적으로 초임계 유체는 기체가 고온 고압 조건에서 임계점에 도달하였을 때 갖는 액체 및 기체의 성질을 지니고 있으며, 화학적으로 비극성 용매와 유사한 극성을 지니고 있으며 이러한 특성으로 인해 초임계 유체는 지용성 물질의 추출에 사용되고 있다(J. Chromatogr. A. 1998;479:200-205).Decompression by carbon dioxide and extraction by supercritical extraction by high temperature means supercritical fluid extraction. Generally, supercritical fluids have the properties of liquid and gas when gas reaches the critical point at high temperature and high pressure, and chemically have polarity similar to that of nonpolar solvent. Due to this characteristic, supercritical fluid (J. Chromatogr. A. 1998; 479: 200-205).
이산화탄소는 초임계 유체기기의 작동으로 압력 및 온도가 임계점까지 이르는 과정을 거치면서 액체 및 기체 성질을 동시에 지닌 초임계 유체가 되고 그 결과 지용성 용질에 대한 용해도가 증가한다. 초임계 이산화탄소가 일정량의 시료를 함유한 추출 용기를 통과하게 되면 시료에 함유된 지용성 물질은 초임계 이산화탄소에 추출되어 나온다.Carbon dioxide is a supercritical fluid with both liquid and gaseous nature, with the operation of supercritical fluid equipment reaching its critical pressure and temperature, resulting in increased solubility in fat-soluble solutes. When supercritical carbon dioxide passes through an extraction vessel containing a certain amount of sample, the lipophilic substance contained in the sample is extracted into supercritical carbon dioxide.
지용성 물질을 추출한 후 추출 용기에 남아있는 시료에 다시 소량의 공용매가 함유된 초임계 이산화탄소를 흘려 통과시키면 순수한 초임계 이산화탄소만으로는 추출되지 않았던 성분들이 추출되어 나오게 할 수 있다. When the supernatant carbon dioxide containing a small amount of cosolvent is passed through the sample remaining in the extraction vessel after extracting the lipid-soluble substance, components that were not extracted by pure supercritical carbon dioxide can be extracted.
본 발명의 초임계추출법에 사용되는 초임계 유체는 초임계 이산화탄소 또는 이산화탄소에 추가적으로 공용매를 혼합한 혼합유체를 사용함으로써 효과적으로 유효 성분을 추출할 수 있다. 이러한 공용매는 클로로포름, 에탄올, 메탄올, 물, 에틸아세테이트, 헥산 및 디에틸에테르로 이루어진 군에서 선택되는 1종 또는 2종 이상의 혼합물을 사용할 수 있다.The supercritical fluid used in the supercritical extraction method of the present invention can effectively extract an active ingredient by using a mixed fluid in which a cosolvent is further mixed with supercritical carbon dioxide or carbon dioxide. These co-solvents may be used alone or in admixture of two or more selected from the group consisting of chloroform, ethanol, methanol, water, ethyl acetate, hexane and diethyl ether.
추출된 시료는 대부분 이산화탄소를 함유하고 있는데 이산화탄소는 실온에서 공기 중으로 휘발되므로 상기 방법으로 얻은 추출물을 화장료 조성물로서 사용할 수 있으며, 공용매는 감압증발기로 제거할 수 있다.Most of the extracted samples contain carbon dioxide. Since the carbon dioxide is volatilized into air at room temperature, the extract obtained by the above method can be used as a cosmetic composition, and the cosolvent can be removed by a reduced pressure evaporator.
초음파 추출법에 사용할 수 있는 추출용매는 클로로포름, 에탄올, 메탄올, 물, 에틸아세테이트, 헥산 및 디에틸에테르로 이루어진 군에서 선택되는 1종 또는 2종 이상의 혼합물을 사용할 수 있다.As the extraction solvent which can be used for the ultrasonic extraction method, one or a mixture of two or more selected from the group consisting of chloroform, ethanol, methanol, water, ethyl acetate, hexane and diethyl ether can be used.
추출된 시료는 진공 여과하여 여과액을 회수한 후 감압증발기로 제거하고, 동결 건조하는 통상의 추출물 제조방법을 통해 추출물을 얻을 수 있다.The extracted sample is recovered by vacuum filtration, and the filtrate is recovered, and the extract is removed by a vacuum evaporator and freeze-dried to obtain an extract.
또한, 본 발명의 황금땅콩 추출물은 통상적인 정제 과정 및/또는 발효 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 이용한 분리, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 황금땅콩 추출물에 포함된다고 해석된다. 또한, 효모균, 유산균, 바실러스속 균 및 이의 혼합물로 이루어지는 군중에서 선택되는 균으로 20 내지 40 ℃의 온도 조건 하에서 pH 5 내지 7을 유지하면서, 1 내지 7 일간 발효시켜 얻어지는 발효물도 본 발명의 황금땅콩 추출물에 포함된다고 해석된다.In addition, the golden peanut extract of the present invention also includes an extract obtained by a conventional purification process and / or a fermentation process. For example, by separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatographies (made for separation by size, charge, hydrophobicity or affinity), and the like, The fraction is also interpreted to be included in the golden peanut extract of the present invention. The fermentation product obtained by fermentation for 1 to 7 days while maintaining the pH of 5 to 7 under a temperature condition of 20 to 40 DEG C as a bacterium selected from the group consisting of yeast, lactic acid bacteria, Bacillus subtilis bacteria and mixtures thereof, It is interpreted to be included in the extract.
또한, 본 발명의 황금땅콩 추출물은 포제법을 이용하여 얻어낸 추출물도 포함한다. 포제란 한방이론에 근거하여 약재를 가공 처리함으로써 약재 본래의 성질을 변화시키는 제약 기술이다. 주로 찌거나, 삶거나, 불에 볶거나, 불에 굽거나 달구는 공정 또는 이들이 혼합된 공정의 방법을 말한다. 본 발명에서는 황금땅콩을 쪄서 건조시킨 후 이를 이용하여 추출물을 제조하였다. In addition, the golden peanut extract of the present invention includes the extract obtained by the pulverization method. Fojera is a pharmaceutical technology that changes the original properties of medicines by processing the medicines based on the oriental medicine theory. Mainly refers to the process of steaming, boiling, roasting, roasting, burning, or mixing processes. In the present invention, golden peanuts were steamed and dried to prepare an extract.
본 발명의 황금땅콩 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The golden peanut extract of the present invention can be prepared in a powder state by an additional process such as vacuum distillation and freeze drying or spray drying.
본 발명의 황금땅콩 추출물은 항산화 효과 및 세포 이동 효과(Cell Migration)가 우수하여 피부 항노화 효과가 우수하다.The golden peanut extract of the present invention is excellent in antioxidative effect and cell migration (cell migration), and thus has excellent anti-aging effect on skin.
또한, 본 발명의 바람직한 실시예에 따르면, 본 발명의 땅콩 추출물의 함량은 화장료 조성물의 총 중량에 대하여 0.0001∼30.0중량%, 바람직하게는 0.001∼20.0중량%이다. 이때 땅콩 추출물의 총 중량이 0.0001중량% 미만일 때에는 그 효과가 나타나기 어렵고, 30.0중량%를 초과할 때에는 피부에 자극을 유발할 가능성이 높으며 제형의 안정화에도 큰 영향을 미칠 수 있다.According to a preferred embodiment of the present invention, the content of the peanut extract of the present invention is 0.0001 to 30.0% by weight, preferably 0.001 to 20.0% by weight based on the total weight of the cosmetic composition. When the total weight of the peanut extract is less than 0.0001% by weight, the effect of the peanut extract is less likely to be exhibited. When the total weight of the peanut extract is more than 30.0% by weight, there is a high possibility of causing skin irritation.
본 발명의 화장품 조성물에 포함되는 성분은 유효 성분으로서의 황금땅콩 추출물 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The ingredients contained in the cosmetic composition of the present invention include ingredients conventionally used in cosmetic compositions in addition to the golden peanut extract as an active ingredient and include conventional additives such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavors, And a carrier.
본 발명의 화장료 조성물은 당 업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다.
The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used in the form of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, , Oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto.
실시예Example 1. One. 황금땅콩Golden peanut 추출물의 제조 Preparation of extract
껍질이 제거된 건조된 황금땅콩 100g을 분말화한 후 메시를 이용하여 미세하게 만들었다. 그 후 물 및 에탄올의 비율을 7:3으로 조정한 70% 에탄올 1,000 ㎖를 가하여 실온에서 4일 동안 침출하였다. 이를 여과하고 여액을 진공 농축하여 건조 추출물을 얻었으며, 추출 수율은 34.8g/100g이었다. 상기 건조 추출물을 10% (w/v) 농도가 되도록 30% 1,3-부틸렌 글리콜 용액 및 정제수를 이용하여 용해하고 여과하여 황금땅콩 추출물을 제조하였다.100 g of dried peanuts were peeled off and powdered and finely ground using a mesh. Thereafter, 1,000 ml of 70% ethanol adjusted to a ratio of water and ethanol of 7: 3 was added and the mixture was leached at room temperature for 4 days. The solution was filtered and the filtrate was concentrated in vacuo to give a dry extract. The extraction yield was 34.8 g / 100 g. The dried extract was dissolved in 30% 1,3-butylene glycol solution and purified water to a concentration of 10% (w / v) and filtered to prepare a golden peanut extract.
비교예Comparative Example 1. 땅콩 추출물의 제조 1. Preparation of peanut extract
껍질이 제거된 건조된 일반 땅콩 100g을 분말화한 후 메시를 이용하여 미세하게 만들었다. 그 후 물 및 에탄올의 비율을 7:3으로 조정한 70% 에탄올 1,000 ㎖를 가하여 실온에서 4일 동안 침출하였다. 이를 여과하고 여액을 진공 농축하여 건조 추출물을 얻었으며, 추출 수율은 34.8g/100g이었다. 상기 건조 추출물을 10% (w/v) 농도가 되도록 30% 1,3-부틸렌 글리콜 용액 및 정제수를 이용하여 용해하고 여과하여 땅콩 추출물을 제조하였다.
100 g of dried peanuts, which had been peeled off, were pulverized and finely ground using a mesh. Thereafter, 1,000 ml of 70% ethanol adjusted to a ratio of water and ethanol of 7: 3 was added and the mixture was leached at room temperature for 4 days. The solution was filtered and the filtrate was concentrated in vacuo to give a dry extract. The extraction yield was 34.8 g / 100 g. The dried extract was dissolved in 30% 1,3-butylene glycol solution and purified water to a concentration of 10% (w / v) and filtered to prepare peanut extract.
비교예Comparative Example 2. 녹두 추출물의 제조 2. Preparation of mung bean extract
정제수로 세척하고 건조시킨 녹두를 분말화한 후 300메시를 이용하여 미세하게 만들었다. 그 후 물 및 에탄올의 비율을 7:3으로 조정한 70% 에탄올 1,000 ㎖를 가하여 실온에서 4일 동안 침출하였다. 이를 여과하고 여액을 진공 농축하여 건조 추출물을 얻었으며, 추출 수율은 34.8g/100g이었다. 상기 건조 추출물을 10% (w/v) 농도가 되도록 30% 1,3-부틸렌 글리콜 용액 및 정제수를 이용하여 용해하고 여과하여 녹두 추출물을 제조하였다.
The mung bean was washed with purified water and dried. The dried mung bean was powdered and made fine using 300 mesh. Thereafter, 1,000 ml of 70% ethanol adjusted to a ratio of water and ethanol of 7: 3 was added and the mixture was leached at room temperature for 4 days. The solution was filtered and the filtrate was concentrated in vacuo to give a dry extract. The extraction yield was 34.8 g / 100 g. The dried extract was dissolved in 30% 1,3-butylene glycol solution and purified water to a concentration of 10% (w / v) and filtered to prepare mung bean extract.
실험예Experimental Example 1: One: 황금땅콩Golden peanut 추출물의 항산화 효과 Antioxidative effect of extract
본 실험예 1은 실시예 1 및 비교예 1의 황금땅콩 추출물과 땅콩 추출물의 항산화 효과를 측정하기 위해 DPPH법을 이용하여 항산화 효과(자유라디칼 소거율)를 측정하였다.The antioxidative effect (free radical scavenging ratio) of the peanut extract and the peanut extract of Example 1 and Comparative Example 1 was measured using the DPPH method.
DPPH법은 DPPH(2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl) 자유라디칼이라는 유리기를 사용하여 환원력에 의한 항산화 효과를 측정한다. 피검 물질(황금땅콩 추출물)에 의해 DPPH가 환원되어 흡광도가 감소하는 정도를 공시험액의 흡광도와 비교하여 파장 517nm에서 항산화 효과를 측정하였다.
The DPPH method measures the antioxidative effect by reducing power using a free radical called DPPH (2,2-Di (4-tert-octylphenyl) -1-picrylhydrazyl) free radical. The antioxidant effect was measured at a wavelength of 517 nm by comparing the absorbance of the DPPH reduced by the test substance (golden peanut extract) with the absorbance of the blank test solution.
간단한 측정방법으로서As a simple measurement method
① 땅콩 추출물과 황금땅콩 추출물을 에탄올 100%, 에탄올 70%, 정제수에 각각 0.01%, 0.05%, 0.1%, 0.5%, 1%, 10% 농도로 각각 희석하여 샘플을 준비한다. ① Prepare a sample by diluting peanut extract and golden peanut extract with concentrations of 0.01%, 0.05%, 0.1%, 0.5%, 1% and 10% in
② 대조군으로 α-tocopherol 200uM, 400uM을 준비한다.② Prepare α-
③ 각각의 샘플 용액을 0.2mM DPPH 용액과 1:1로 섞어준다.③ Mix each sample solution 1: 1 with 0.2 mM DPPH solution.
④ 96well에 100ul씩 넣고 암실에서 30분 반응 시킨다④ Add 100ul to 96 well and react in the dark room for 30 minutes.
⑤ 30분 후 ELISA기기로 517nm에서 흡광도를 측정한다
⑤ After 30 minutes, absorbance is measured at 517 nm with an ELISA instrument
도 1은 상기한 항산화 효과 측정 결과를 도시한 것이다. 도 1(a)는 황금땅콩 추출물 및 일반 땅콩 추출물을 에탄올 70%에 희석한 경우, 도 1(b)는 증류수에 희석한 경우, 도 1(c)는 에탄올 100%에 희석한 경우의 결과를 도시한 것이다. 도 1을 보면, 3 가지 경우 모두에서 황금땅콩 추출물(실시예 1)은 비교예 1의 일반 땅콩 추출물과 비교하여 항산화 효과가 크게 증가한 것을 확인할 수 있었다. 대조군은 Vitamin E(토코페롤)를 사용하였으며, 본 발명의 실시예 1이 비교예 1에 비해 항산화 효과가 우수한 것을 확인할 수 있었다. Fig. 1 shows the result of the antioxidative effect measurement. Fig. 1 (a) shows the results when the golden peanut extract and the common peanut extract were diluted in 70% ethanol, Fig. 1 (b) diluted in distilled water and Fig. 1 (c) Respectively. FIG. 1 shows that the golden peanut extract (Example 1) significantly increased the antioxidative effect compared to the peanut extract of Comparative Example 1 in all three cases. Vitamin E (tocopherol) was used as a control, and it was confirmed that Example 1 of the present invention is superior to Comparative Example 1 in antioxidative effect.
실험예Experimental Example 2: 세포 이동 효과 2: cell migration effect
섬유아세포의 이동성(migration) 촉진 효과를 분석하는 것은 세포의 상처 치유 효과를 측정하는 일반적인 방법 중 하나이다. 따라서 섬유아세포 HDFn Cell을 24 웰 플레이트에 confluent하게 키운 다음 마이크로팁을 이용하여 세포를 긁어내고 (in vitro wounding) 각각 실시예 1의 황금땅콩 추출물과 비교예 1의 땅콩 추출물과 비교예 2의 녹두 추출물을 1ppm, 1000ppm 농도로 세포에 처리한 다음 24시간 반응시켰다. 24시간 후 현미경 하에서 이동된 세포를 사진으로 캡쳐하고, 상처(wounding) 위치로 이동된 세포의 밀도를 파악하였다.Analysis of the promoting effect of migration of fibroblasts is one of the common methods of measuring the wound healing effect of cells. Therefore, the fibroblast HDFn cells were confluently cultured in a 24-well plate, and then cells were scraped in vitro using microtip, and the peanut extract of Example 1 and the peanut extract of Comparative Example 1 and the mung bean extract of Comparative Example 2 Was treated with 1ppm and 1000ppm of the cells, followed by reaction for 24 hours. After 24 hours, the cells migrated under the microscope were photographed and the density of cells transferred to the wounding location was determined.
본 발명의 실시예 1에서 수득한 황금땅콩 추출물의 세포 이동(Cell Migration) 효과를 확인하기 위해 비교예 1 내지 2의 추출물과 비교하여 도 2a 내지 도 2c에 나타내었다. 도 2d는 대조군을 도시한 것이다.Compared with the extracts of Comparative Examples 1 and 2, the peanut extracts obtained in Example 1 were compared with the extracts of Comparative Examples 1 and 2 to confirm the cell migration effect. Figure 2d shows a control group.
HDFn cell에서의 이동성(migration) 평가 결과, 도 2a에 나타낸 실시예 1이 비교예 1(도 2b) 및 비교예 2(도 2c)에 비해 더 뛰어난 세포 이동 효과를 나타냄을 알 수 있다.또한, 24시간이 지난 후 농도별로 실시예 1이 비교예 1 내지 2에 비해 가운데 빈 공간으로 세포 이동이 활발하게 이루어졌음을 확인할 수 있다.
As a result of the migration evaluation in the HDFn cell, it can be seen that Example 1 shown in FIG. 2A shows a better cell migration effect than Comparative Example 1 (FIG. 2B) and Comparative Example 2 (FIG. 2C) After 24 hours, it can be seen that the cell migration was actively performed in the middle empty space in Example 1 compared with Comparative Examples 1 and 2 by concentration.
실험예Experimental Example 3: 피부탄력 개선 효과의 평가 3: Evaluation of skin elasticity improvement effect
본 발명의 실시예 1에서 수득한 황금땅콩 추출물의 피부 탄력 개선 효과를 확인하기 위해, 황금땅콩 추출물을 함유하는 조성물을 포함하는 화장료(제형예 1)를 제조하여, 피부 탄력 개선 효과를 알아보기 위하여 다음과 같이 실험을 실시하였다. 이때 하기 표 1과 같이 황금땅콩 추출물 대신 비교예 1의 일반 땅콩 추출물을 포함하는 비교제형예 1 및 녹두 추출물을 포함하는 비교제형예 2, 추출물을 포함하지 않는 대조군인 비교제형예 3의 화장료를 제조하여 피부 탄력 개선 효과를 비교하였다. To confirm the effect of improving the skin elasticity of the golden peanut extract obtained in Example 1 of the present invention, a cosmetic (Formulation Example 1) comprising a composition containing a golden peanut extract was prepared and its skin elasticity improvement effect was examined The following experiment was conducted. Comparative Example 1 containing Comparative Peanut Extract of Comparative Example 1, Comparative Formulation Example 2 containing mung bean extract, and Comparative Example 3 containing no extract were prepared as shown in Table 1 below, The effect of improving skin elasticity was compared.
황금땅콩 추출물을 함유한 크림(제형예 1) 및 비교제형예 1 내지 비교제형예 3 크림의 피부탄력 개선 효과를 다음과 같이 평가하였다.The cream containing the peanut extract of Golden Ripe (Formulation Example 1) and Comparative Formulation Examples 1 to 3 The skin elasticity improvement effect of the cream was evaluated as follows.
실험자(20세-35세의 여성) 15명을 대상으로 얼굴 오른쪽 부위에는 제형예 1의 크림을, 얼굴 왼쪽 부위에는 비교제형예 1 내지 비교제형예 3의 크림을 각각 1일 2회씩 연속 4주간 도포하였다.15 creams (20 to 35 years old) were applied to the right side of the face with the cream of Formulation Example 1 and the left side of the face with the creams of Comparative Formulation Examples 1 to 3 twice a day for 4 consecutive weeks Respectively.
실험완료 후 피부 탄력 개선 효과는 제품 사용 전과 4 주간 사용 후에 피부탄력측정기(cutometer SEM 575, C+K Electronic Co., Germany)를 이용하여 측정하였다. 결과는 하기 표 2에 피부탄력측정기(Cutometer SEM 575)의 ΔR8값으로 기재하였는데 R8값은 피부의 점탄성(viscoelasticity)의 성질을 나타낸다.The skin elasticity improvement effect after the completion of the experiment was measured using a skin elasticity meter (SEM 575, C + K Electronic Co., Germany) before and 4 weeks after use of the product. The results are shown in Table 2 as ΔR 8 values of a skin elasticity measuring instrument (Cutometer SEM 575). The R 8 value indicates the viscoelasticity of the skin.
하기 표 2에 나타난 바와 같이 황금땅콩 추출물을 함유한 제형예 1의 크림을 도포한 실험자의 피부 탄력개선 효과가 가장 우수함을 알 수 있다.As shown in the following Table 2, it can be seen that the skin elasticity improving effect of the creamer of
1
One
3
3
(실시예 1)Golden peanut extract
(Example 1)
(비교예 1)Peanut extract
(Comparative Example 1)
(비교예 2)Mung bean extract
(Comparative Example 2)
(n=15, p<0.05)
(n = 15, p < 0.05)
이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140044128A KR101608882B1 (en) | 2014-04-14 | 2014-04-14 | Cosmetic Composition Comprising Golden Peanut Extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140044128A KR101608882B1 (en) | 2014-04-14 | 2014-04-14 | Cosmetic Composition Comprising Golden Peanut Extracts |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150118368A KR20150118368A (en) | 2015-10-22 |
KR101608882B1 true KR101608882B1 (en) | 2016-04-04 |
Family
ID=54426834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140044128A Expired - Fee Related KR101608882B1 (en) | 2014-04-14 | 2014-04-14 | Cosmetic Composition Comprising Golden Peanut Extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101608882B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180060201A (en) * | 2016-11-28 | 2018-06-07 | 한국과학기술연구원 | A composition for treating dermatitis comprising aerial part of Arachis hypogaea L. extract and fractions and use thereof |
-
2014
- 2014-04-14 KR KR1020140044128A patent/KR101608882B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20150118368A (en) | 2015-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101333209B1 (en) | Cosmetic composition for preventing skin aging comprising surface-modified gold nanoparticle by phytochemical | |
KR20170019829A (en) | A Cosmetic Composition Having An Antioxidation, Anti-Inflamation Effects Contaning Rosemarimus Officinalis, Chrysanthemum Indicum Flower , Magnolia Kobus Flower , Polygonum Cuspidatum Root Extracts | |
KR101308669B1 (en) | Cosmetic composition with the nebaneba complex of hibiscus esculentus, laminaria japonica, dioscorea opposita, corchorus olitorius and nelumbo nucifera, polyglutamic acid | |
EP1621194A1 (en) | Active oxygen eliminator originating in natural material and use of the same | |
KR20180065166A (en) | Cosmetic composition for skin whitening containing pancratium maritimum extract and blue lotus extract | |
KR20110068949A (en) | Plum tree extract, method for producing and use thereof | |
JP2009035521A (en) | Topical skin preparation | |
KR101608882B1 (en) | Cosmetic Composition Comprising Golden Peanut Extracts | |
KR20220053224A (en) | Cosmetic composition for improving skin elasticity comprising mixed extracts of melaleuca alternifolia leaf, mentha piperita leaf, houttuynia cordata, camellia sinensis leaf, morinda citrifolia and petroselinum sativum as active ingredient | |
KR20160016382A (en) | Skin External Composition Comprising the Niaouli | |
KR101537293B1 (en) | Antioxidant cosmetic composition containing extracts of processed Chrysanthemum indicum or Citrus unshiu peel | |
JP2000239145A (en) | Anti-allergic agent, beautifully whitening agent and skin cosmetic | |
KR20190079338A (en) | A cosmetic composition comprising fractions of extracts of flower of Forsythia koreana as an active ingredient | |
KR20050101217A (en) | Compound, process for producing the same and use thereof | |
KR20230046573A (en) | Cosmetic composition comprising extracts of clove for anti-oxidation, anti-wrinkle, improving skin elasticity and skin whitening | |
KR102072111B1 (en) | Antioxidant composition comprising defatted perilla extract as effective component and manufacturing method thereof | |
KR102076722B1 (en) | Cosmetic Compositions With Prunus mume Extracts | |
KR101996547B1 (en) | Cosmetic composition with skin whitening effect containing diphylleia grayi extract | |
KR100920897B1 (en) | Antioxidant Cosmetic Composition Containing Nanovegetal Vitatox and Blue Lotus Extract | |
KR101822043B1 (en) | Cosmetic Compositions Containing complex Extracts of Nymphaea Caerulea and Cetraria islandica | |
JP3128727B2 (en) | Active oxygen scavenger | |
KR20020047762A (en) | Cosmetics comprising sanguisorba root extracts for antioxidation | |
KR101888999B1 (en) | Cosmetic composition containing ultrasonicating extract of mahkota dewa | |
KR102366234B1 (en) | Skin wrinkle improvement effects of solvent extracts from Desmodium sequax Wall or fractions thereof | |
KR20150132753A (en) | A preparation method of a leaf extract of Morus alba having antioxidant and antimicrobial activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20140414 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20160112 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20160322 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20160329 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20160330 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20190109 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20190109 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20191226 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20191226 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20201222 Start annual number: 6 End annual number: 6 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20230109 |